-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
-
5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research
By Monte M. Winslow, PhD Posted: February 2018 Over 4 rainy days in San Diego, California, more than 220 participants from 15 different countries heard presentations that spanned a very wide range of basic, translational, and clinical lung cancer research. This joint conference between the IASLC and the American Association for Cancer Research (AACR) was…
-
Tony S. K. Mok, BMSc, MD
Posted: February 2018 Tony S. K. Mok, BMSc, MD, has been elected to an International Oncologist seat of the 2019-2020 ASCO Board of Directors. Dr. Mok is the Li Shu Fan Medical Foundation Named Professor of Clinical Oncology and chair of clinical oncology at The Chinese University of Hong Kong. He co-founded the Lung Cancer…
-
John V. Heymach, MD, PhD
Posted: February 2018 John V. Heymach, MD, PhD, has been named a Fellow (Medical Sciences) of the American Association for the Advancement of Science (AAAS). Dr. Heymach is the Chair of Thoracic/Head and Neck Medical Oncology and a Professor in the Departments of Thoracic Head and Neck Medical Oncology and Cancer Biology at The University…
View ILCN Archives
Provider Resources
Popular Articles